CC(C)C(=O)NCC1CCC2(CCN(Cc3ccc(-c4cccc(Cl)c4)o3)CC2)O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?